These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23652159)

  • 21. Patterns of physician prescribing for opioid maintenance treatment in Ontario, Canada in 2014.
    Guan Q; Khuu W; Spithoff S; Kiran T; Kahan M; Tadrous M; Martins D; Leece P; Gomes T
    Drug Alcohol Depend; 2017 Aug; 177():315-321. PubMed ID: 28733101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Auditory event-related potentials in methadone substituted opiate users.
    Wang GY; Kydd R; Russell BR
    J Psychopharmacol; 2015 Sep; 29(9):983-95. PubMed ID: 26038111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abstinence orientation and treatment practice: an analysis of German settings providing opioid maintenance therapy.
    Trautmann S; Wittchen HU
    Subst Use Misuse; 2012 Jan; 47(1):22-30. PubMed ID: 22060728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methadone maintenance-lessons from two systems in China.
    Lee SS; Newman R
    Harm Reduct J; 2017 Sep; 14(1):66. PubMed ID: 28946906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacoepigenomics of opiates and methadone maintenance treatment: current data and perspectives.
    Marie-Claire C; Jourdaine C; Lépine JP; Bellivier F; Bloch V; Vorspan F
    Pharmacogenomics; 2017 Sep; 18(14):1359-1372. PubMed ID: 28841113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methadone is no panacea.
    Spence D
    BMJ; 2012 Aug; 345():e5670. PubMed ID: 22915733
    [No Abstract]   [Full Text] [Related]  

  • 27. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
    Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
    Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran.
    Farnia M; Ebrahimi B; Shams A; Zamani S
    Int J Drug Policy; 2010 Sep; 21(5):422-4. PubMed ID: 20413287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abstinence versus agonist maintenance treatment: an outdated debate?
    Uchtenhagen A
    Eur Addict Res; 2013; 19(6):283-6. PubMed ID: 23651992
    [No Abstract]   [Full Text] [Related]  

  • 30. Pain and Opioid Addiction: A Systematic Review and Evaluation of Pain Measurement in Patients with Opioid Dependence on Methadone Maintenance Treatment.
    Dennis BB; Bawor M; Paul J; Plater C; Pare G; Worster A; Varenbut M; Daiter J; Marsh DC; Desai D; Thabane L; Samaan Z
    Curr Drug Abuse Rev; 2016; 9(1):49-60. PubMed ID: 27021147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short term health-related quality of life improvement during opioid agonist treatment.
    Nosyk B; Bray JW; Wittenberg E; Aden B; Eggman AA; Weiss RD; Potter J; Ang A; Hser YI; Ling W; Schackman BR
    Drug Alcohol Depend; 2015 Dec; 157():121-8. PubMed ID: 26511766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medication-assisted treatment with methadone: assessing the evidence.
    Fullerton CA; Kim M; Thomas CP; Lyman DR; Montejano LB; Dougherty RH; Daniels AS; Ghose SS; Delphin-Rittmon ME
    Psychiatr Serv; 2014 Feb; 65(2):146-57. PubMed ID: 24248468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experiences and Perceived Social Support among Iranian Men on Methadone Maintenance Therapy: A Qualitative Study.
    Aghakhani N; Lopez V; Cleary M
    Issues Ment Health Nurs; 2017 Sep; 38(9):692-697. PubMed ID: 28745916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use and misuse of opioid replacement therapies: a Queensland study.
    Smirnov A; Kemp R
    Subst Use Misuse; 2012 Jan; 47(1):78-85. PubMed ID: 22216993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Work and the journey to recovery: exploring the implications of welfare reform for methadone maintenance clients.
    Monaghan M; Wincup E
    Int J Drug Policy; 2013 Nov; 24(6):e81-6. PubMed ID: 24360401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "Should I stay or should I go?" Coming off methadone and buprenorphine treatment.
    Winstock AR; Lintzeris N; Lea T
    Int J Drug Policy; 2011 Jan; 22(1):77-81. PubMed ID: 20956077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reducing stigma through education to enhance Medication-Assisted Recovery.
    Woods JS; Joseph H
    J Addict Dis; 2012; 31(3):226-35. PubMed ID: 22873184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shouting through bullet-proof glass: some reflections on pharmacotherapy provision in one Australian clinic.
    Crawford S
    Int J Drug Policy; 2013 Nov; 24(6):e14-7. PubMed ID: 24007689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opiate users' perceived barriers against attending methadone maintenance therapy: a qualitative study in China.
    Lin C; Wu Z; Detels R
    Subst Use Misuse; 2011; 46(9):1190-8. PubMed ID: 21417558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 'Not just methadone Tracy': transformations in service-user identity following the introduction of hepatitis C treatment into Australian opiate substitution settings.
    Rance J; Treloar C;
    Addiction; 2014 Mar; 109(3):452-9. PubMed ID: 24678545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.